BMO ARK Genomic Revolution Fund (NEO:ARKG)
10.68
-0.35 (-3.17%)
At close: Jul 7, 2025
NEO:ARKG Holdings Information
NEO:ARKG is an equity ETF with a total of 35 individual holdings. The top holdings are CRISPR Therapeutics AG stock at 9.61%, Tempus AI at 9.27%, Twist Bioscience at 7.37%, Guardant Health at 6.59%, and Recursion Pharmaceuticals at 5.56%.
Total Holdings
25
Top 10 Percentage
60.08%
Asset Class
Equity
ETF Category
Theme
Assets
4.40M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | CRSP | CRISPR Therapeutics AG | 9.61% |
2 | TEM | Tempus AI, Inc. | 9.27% |
3 | TWST | Twist Bioscience Corporation | 7.37% |
4 | GH | Guardant Health, Inc. | 6.59% |
5 | RXRX | Recursion Pharmaceuticals, Inc. | 5.56% |
6 | NTRA | Natera, Inc. | 5.32% |
7 | ADPT | Adaptive Biotechnologies Corporation | 4.39% |
8 | PSNL | Personalis, Inc. | 4.37% |
9 | CDNA | CareDx, Inc | 3.85% |
10 | SDGR | Schrödinger, Inc. | 3.77% |
11 | TXG | 10x Genomics, Inc. | 3.62% |
12 | IONS | Ionis Pharmaceuticals, Inc. | 3.38% |
13 | BEAM | Beam Therapeutics Inc. | 3.13% |
14 | VCYT | Veracyte, Inc. | 3.03% |
15 | NTLA | Intellia Therapeutics, Inc. | 2.63% |
16 | ILMN | Illumina, Inc. | 2.47% |
17 | ABSI | Absci Corporation | 2.34% |
18 | ARCT | Arcturus Therapeutics Holdings Inc. | 2.09% |
19 | MASS | 908 Devices Inc. | 1.76% |
20 | NRIX | Nurix Therapeutics, Inc. | 1.68% |
21 | AMGN | Amgen Inc. | 1.52% |
22 | QSI | Quantum-Si incorporated | 1.46% |
23 | VEEV | Veeva Systems Inc. | 1.34% |
24 | n/a | Usd | 1.33% |
25 | PACB | Pacific Biosciences of California, Inc. | 1.31% |
As of Jun 30, 2025